- Home
- G vs ELAN Comparison
G vs ELAN Comparison
Compare G & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- G
- ELAN
- Stock Information
- Founded
- G 1997
- ELAN 1954
- Country
- G Bermuda
- ELAN United States
- Employees
- G N/A
- ELAN N/A
- Industry
- G Professional Services
- ELAN Biotechnology: Pharmaceutical Preparations
- Sector
- G Consumer Discretionary
- ELAN Health Care
- Exchange
- G Nasdaq
- ELAN Nasdaq
- Market Cap
- G 7.4B
- ELAN 7.2B
- IPO Year
- G 2007
- ELAN 2018
- Fundamental
- Price
- G $45.08
- ELAN $14.77
- Analyst Decision
- G Buy
- ELAN Buy
- Analyst Count
- G 8
- ELAN 7
- Target Price
- G $47.88
- ELAN $16.17
- AVG Volume (30 Days)
- G 1.3M
- ELAN 4.3M
- Earning Date
- G 08-07-2025
- ELAN 08-07-2025
- Dividend Yield
- G 1.51%
- ELAN N/A
- EPS Growth
- G N/A
- ELAN N/A
- EPS
- G 2.94
- ELAN 0.75
- Revenue
- G $4,850,828,000.00
- ELAN $4,427,000,000.00
- Revenue This Year
- G $6.14
- ELAN $4.33
- Revenue Next Year
- G $6.26
- ELAN $4.75
- P/E Ratio
- G $15.33
- ELAN $19.69
- Revenue Growth
- G 7.35
- ELAN 1.42
- 52 Week Low
- G $32.18
- ELAN $8.02
- 52 Week High
- G $56.76
- ELAN $15.78
- Technical
- Relative Strength Index (RSI)
- G 52.43
- ELAN 55.67
- Support Level
- G $44.86
- ELAN $14.61
- Resistance Level
- G $46.19
- ELAN $15.18
- Average True Range (ATR)
- G 0.80
- ELAN 0.34
- MACD
- G 0.04
- ELAN -0.06
- Stochastic Oscillator
- G 37.45
- ELAN 38.13
About G Genpact Limited
Genpact Ltd is a provider of business process management services. Clients are industry verticals and operate in banking and financial services, insurance, capital markets, consumer product goods, life sciences, infrastructure, manufacturing and services, healthcare, and high-tech. Genpact's services include aftermarket, direct procurement, risk and compliance, human resources, IT, industrial solutions, collections, finance and accounting, and media services. Genpact's end market by revenue is India. It is a General Electric spin-off, which is still a large source of revenue for Genpact.
About ELAN Elanco Animal Health Incorporated
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.